Description
An amiloride derivative with diverse biological activities; an allosteric antagonist of adenosine A2A receptors (Ki = 3.3 µM); inhibits the cation-selective ion channel formed by Vpu at 50 µM, as well as budding of virus-like particles in HeLa cells expressing the HIV-1 proteins Gag and Vpu at 10 µM; blocks the cation-selective ion channels formed by p7; induces necrosis in and reduces the viability of various breast cancer cells at 40 µM; protects against post-ischemic contractile dysfunction and reduces coronary effluent creatine phosphokinase activity in a model of ischemia-reperfusion injury using isolated rat right ventricular free walls
Formal name: 3-amino-N-(aminoiminomethyl)-6-chloro-5-(hexahydro-1H-azepin-1-yl)-2-pyrazinecarboxamide
Synonyms: HMA
Molecular weight: 311.8
CAS: 1428-95-1
Purity: ≥98%
Formulation: A crystalline solid